Array BioPharma Inc. - Product Pipeline Review - 2014

Published: Jan, 2014 | Pages: 60 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Summary

Global Market Direct's pharmaceuticals report, "Array BioPharma Inc. - Product Pipeline Review - 2014" provides data on the Array BioPharma Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Array BioPharma Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Array BioPharma Inc. and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- Array BioPharma Inc. - Brief Array BioPharma Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Array BioPharma Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Array BioPharma Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Array BioPharma Inc.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Array BioPharma Inc.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Array BioPharma Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Array BioPharma Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Array BioPharma Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Array BioPharma Inc. and identify potential opportunities in those areas.

 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Array BioPharma Inc. Snapshot 6
Array BioPharma Inc. Overview 6
Key Information 6
Key Facts 6
Array BioPharma Inc. - Research and Development Overview 7
Key Therapeutic Areas 7
Array BioPharma Inc. - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
Pipeline Products - Partnered Products 12
Partnered Products/Combination Treatment Modalities 13
Pipeline Products - Out-Licensed Products 14
Out-Licensed Products/Combination Treatment Modalities 15
Array BioPharma Inc. - Pipeline Products Glance 17
Array BioPharma Inc. - Clinical Stage Pipeline Products 17
Phase II Products/Combination Treatment Modalities 17
Phase I Products/Combination Treatment Modalities 18
Array BioPharma Inc. - Early Stage Pipeline Products 19
Preclinical Products/Combination Treatment Modalities 19
Discovery Products/Combination Treatment Modalities 20
Array BioPharma Inc. - Drug Profiles 21
ARRY-502 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
ARRY-520 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
ARRY-797 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
ARRY-380 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
ARRY-614 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
AR-460770 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
AR-523 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
AR-786 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
ARRY-005 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
ARRY-006 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
ARRY-111 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
ARRY-981 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
Drugs Targeting Inflammation Pathway 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
Small Molecule To Inhibit B-Raf Kinase For Cancer 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
Array BioPharma Inc. - Pipeline Analysis 39
Array BioPharma Inc. - Pipeline Products by Therapeutic Class 39
Array BioPharma Inc. - Pipeline Products by Target 41
Array BioPharma Inc. - Pipeline Products by Route of Administration 43
Array BioPharma Inc. - Pipeline Products by Molecule Type 44
Array BioPharma Inc. - Pipeline Products by Mechanism of Action 45
Array BioPharma Inc. - Recent Pipeline Updates 47
Array BioPharma Inc. - Dormant Projects 54
Array BioPharma Inc. - Discontinued Pipeline Products 55
Discontinued Pipeline Product Profiles 55
ARRY-797 55
Array BioPharma Inc. - Company Statement 56
Array BioPharma Inc. - Locations And Subsidiaries 58
Head Office 58
Other Locations & Subsidiaries 58
Appendix 59
Methodology 59
Coverage 59
Secondary Research 59
Primary Research 59
Expert Panel Validation 59
Contact Us 60
Disclaimer 60

List of Tables
Array BioPharma Inc., Key Information 6
Array BioPharma Inc., Key Facts 6
Array BioPharma Inc. - Pipeline by Indication, 2014 9
Array BioPharma Inc. - Pipeline by Stage of Development, 2014 10
Array BioPharma Inc. - Monotherapy Products in Pipeline, 2014 11
Array BioPharma Inc. - Partnered Products in Pipeline, 2014 12
Array BioPharma Inc. - Partnered Products/ Combination Treatment Modalities, 2014 13
Array BioPharma Inc. - Out-Licensed Products in Pipeline, 2014 14
Array BioPharma Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2014 15
Array BioPharma Inc. - Phase II, 2014 17
Array BioPharma Inc. - Phase I, 2014 18
Array BioPharma Inc. - Preclinical, 2014 19
Array BioPharma Inc. - Discovery, 2014 20
Array BioPharma Inc. - Pipeline by Therapeutic Class, 2014 40
Array BioPharma Inc. - Pipeline by Target, 2014 42
Array BioPharma Inc. - Pipeline by Route of Administration, 2014 43
Array BioPharma Inc. - Pipeline by Molecule Type, 2014 44
Array BioPharma Inc. - Pipeline Products by Mechanism of Action, 2014 46
Array BioPharma Inc. - Recent Pipeline Updates, 2014 47
Array BioPharma Inc. - Dormant Developmental Projects,2014 54
Array BioPharma Inc. - Discontinued Pipeline Products, 2014 55
Array BioPharma Inc., Other Locations 58